Inventor
MCELROY JOHN F
US23 patents
⚠️ This page may combine multiple inventors who share the name “MCELROY JOHN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MCELROY JOHN F
14 patentsUS8133904B2Mar 13, 2012
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
MCELROY JOHN F26 citations92
US8334282B2Dec 18, 2012
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F8 citations83
US8138216B2Mar 20, 2012
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F11 citations83
US8088809B2Jan 3, 2012
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F13 citations83
US8580768B2Nov 12, 2013
Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F5 citations72
US8252791B2Aug 28, 2012
Purine compounds as cannabinoid receptor blockers
MCELROY JOHN F3 citations62
US8236821B2Aug 7, 2012
Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
MCELROY JOHN F5 citations62
US5308405AMay 3, 1994
Toilet bowl cleaning system
MCELROY JOHN F5 citations62
US8853252B2Oct 7, 2014
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F1 citations51
US8648072B2Feb 11, 2014
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F0 citations51
US8217038B2Jul 10, 2012
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
MCELROY JOHN F1 citations51
US8124802B2Feb 28, 2012
MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity
MCELROY JOHN F0 citations41
US8088926B2Jan 3, 2012
Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
MCELROY JOHN F0 citations41
US8716265B2May 6, 2014
4-quinolinemethanols as anti-malarial agents
MCELROY JOHN F0 citations39
JENRIN DISCOVERY
3 patentsUS9987253B2Jun 5, 2018
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
JENRIN DISCOVERY8 citations83
US9517228B2Dec 13, 2016
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
JENRIN DISCOVERY8 citations83
US9133127B2Sep 15, 2015
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
JENRIN DISCOVERY0 citations51
JENRIN DISCOVERY INC
2 patentsUS7655685B2Feb 2, 2010
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
JENRIN DISCOVERY INC51 citations97
US7666889B2Feb 23, 2010
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
JENRIN DISCOVERY INC15 citations92
JENRIN DISCOVERY LLC
2 patentsUS11179370B2Nov 23, 2021
Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers
JENRIN DISCOVERY LLC0 citations58
US10617673B2Apr 14, 2020
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
JENRIN DISCOVERY LLC0 citations48